Condition
Unipolar Major Depression
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Active Not Recruiting1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05172271Not ApplicableActive Not Recruiting
Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)
NCT01832805Not ApplicableCompletedPrimary
Theta Burst Study Ghent
NCT02637466Phase 4WithdrawnPrimary
Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
Showing all 3 trials